SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-23-000072
Filing Date
2023-10-18
Accepted
2023-10-17 18:40:50
Documents
13
Period of Report
2023-10-17

Document Format Files

Seq Description Document Type Size
1 6-K a2023-10x17appendix3g3h.htm 6-K 21856
2 EX-99.1 exhibit991appendix3g.htm EX-99.1 6590
3 EX-99.2 exhibit992appendix3h.htm EX-99.2 5197
4 exhibit991appendix3g001.jpg GRAPHIC 74256
5 exhibit991appendix3g002.jpg GRAPHIC 57794
6 exhibit991appendix3g003.jpg GRAPHIC 55721
7 exhibit991appendix3g004.jpg GRAPHIC 108891
8 exhibit991appendix3g005.jpg GRAPHIC 90717
9 exhibit991appendix3g006.jpg GRAPHIC 52125
10 exhibit992appendix3h001.jpg GRAPHIC 86729
11 exhibit992appendix3h002.jpg GRAPHIC 51942
12 exhibit992appendix3h003.jpg GRAPHIC 102151
13 exhibit992appendix3h004.jpg GRAPHIC 102448
  Complete submission text file 0001345099-23-000072.txt   1113497
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 231330586
SIC: 2836 Biological Products, (No Diagnostic Substances)